ANAVEX New Website - Untitled Page.png

News, Events and Updates

Search

Anavex Life Sciences Announces Participation at Worldwide NIH Panel at Rare Disease Day®

Feb 22

Anavex Life Sciences Announces Participation at Worldwide NIH Panel at Rare Disease Day®

Anavex Life Sciences Announces Webinar on Rett Syndrome and ANAVEX®2-73 (Blarcamesine) Phase 2 Data

Dec 21, 2020

Anavex Life Sciences Announces Webinar on Rett Syndrome and ANAVEX®2-73 (Blarcamesine) Phase 2 Data

Anavex Life Sciences Announces Completion of ANAVEX®2-73 U.S. Phase 2 Rett Syndrome Clinical Trial

Sep 10, 2020

Anavex Life Sciences Announces Completion of ANAVEX®2-73 U.S. Phase 2 Rett Syndrome Clinical Trial

Stay Connected

Follow us on social media

Webcast Library

Back to Newsroom

Quick Links

Therapeutic Candidates

Patients & Carers

Resources

Corporate Presentation

Forward-Looking Statements

Join our mailing list

Name

Email

Thank you for subscribing!

ANAVEX® is a trademark of Anavex Life Sciences Corp. © 2007-2021. All Rights Reserved.